1 / 6

Antimalarial Drugs Market Trends, Size and Shares by 2026

The demand for antimalarial drugs is on rise, owing to surge in malaria across the globe. Furthermore, rise in awareness initiatives by government is another major factor that contributes to the growth of this market.

MangeshPanhale
Télécharger la présentation

Antimalarial Drugs Market Trends, Size and Shares by 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Antimalarial Drugs Market No. of Pages- 193 Global Opportunity Analysis and Industry Forecast, 2019-2026 Download Report Sample

  2. The global antimalarial drugs market was valued at $711,360 thousand in 2018, and is expected to reach $1,019,396 thousand by 2026, registering a CAGR of 4.6% from 2019 to 2026. Malaria is a deadly infectious disease, which is transmitted through the bite of female Anopheles mosquito. The infection spreads to liver cells where the parasites multiply at a fast rate to invade red blood cells. These parasites further grow and mature in red blood cells to form merozoites, which are released upon the rupture of red blood cells to invade other blood cells. This leads to fever, tiredness, vomiting, headaches, impaired consciousness, multiple convulsions, and abnormal bleeding. Hence, the drugs which are employed in the treatment of malarial infection are called as antimalarial drugs. There are different types of antimalarial drugs such as quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others available in the market. The major factor that drives the growth of the antimalarial drugs market include rise in prevalence of malaria in developing countries. Furthermore, rise in awareness initiatives by governments and surge in research for new antimalarial drugs are some of the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is a major factor that restricts the growth of the antimalarial drugs market in the region. Conversely, growth opportunities exhibited by emerging economies are expected to offer lucrative opportunities during the forecast period. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2760 Antimalarial Drugs Market Download Report Sample

  3. The antimalarial drugs market size is studied on the basis of drug class, distribution channel, and region to provide a detailed assessment of the market. On the basis of drug class, it is segmented into quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others. By distribution channel, it is bifurcated into hospital pharmacy, retail pharmacy, and e-commerce & other distribution channel. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA). According to drug class, the others segment occupied the major share of the antimalarial drugs market. Furthermore, the segment is also expected to exhibit the fastest growth rate during the forecast period, owing to the factor that malaria parasites have successfully developed resistance against most of the drugs already available in the market. By distribution channel, the hospital pharmacy segment acquired the major share due to rise in number of hospitals worldwide. Furthermore, antimalarial drugs are prescription-based medications, which are mostly prescribed by the specialized healthcare professionals available in hospitals; thereby, propelling the growth of this segment. Conversely, the e-commerce segment is expected to exhibit the fastest growth rate during the forecast period, owing to surge in the use of internet across the globe. Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2760 Antimalarial Drugs Market Download Report Sample

  4. The Major Key Players Are: • Alvizia Healthcare Pvt. Ltd. • Bayer AG • F. Hoffmann-La Roche Ltd • GlaxoSmithKline Plc • Ipca Laboratories Ltd. • Merck & Co., Inc • Novartis AG • Pfizer Inc. • Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories) • Zydus Cadila. Antimalarial Drugs Market Download Report Sample

  5. Key Findings of the Study: • Quinine check occupied approximately one-fourth share of the global antimalarial drugs market in 2018. • The others segment in drug class is anticipated to grow with the highest CAGR throughout the forecast period. • The hospital pharmacy drugs segment accounted for less than two-third share of the market in 2018. • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA. Antimalarial Drugs Market Download Report Sample

  6. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Antimalarial Drugs Market Download Report Sample

More Related